PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.

Oncotarget · 2016 · PMC5216777 · PMID 27329591

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Moreover, piR-651 (p<0.0001) and piR-20582 (p=0.0003) were significantly upregulated in patient lymph nodes compared to RLN, while piR-20365 (p=0.0505) showed a trend to upregulation (Figure 3A–3C ). piR-651 and clinical outcome Only piR-651 expression was associated with clinical outcome.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.